Tony Phengrasamy
Datos Biográficos
| ID | 10727331 |
|---|---|
| NOMBRE | Tony Phengrasamy |
| NOMBRES | Tony |
| APELLIDO | Phengrasamy |
| FIRMA | PHENGRASAMY T |
| AFILIACIONES | University of California, San Francisco |
| VERIFICADO | No |
| TOTAL DE OBRAS | 2 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 2 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2015 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2016 |
| ÍNDICE H | 0 |
Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System
BACKGROUND: Placebo-controlled and open-label studies have demonstrated the safety and efficacy of daily oral preexposure prophylaxis (PrEP) in preventing HIV infection, but data are limited on real-world PrEP use. METHODS: We conducted a cohort study from July 2012 through June 2015 of Kaiser Permanente Northern California members initiating PrEP. We assessed pharmacy refill adherence and discontinuation, decreases in estimated glomerular filtra…
No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting
Referrals for and initiation of preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection increased dramatically in a large clinical practice setting since 2012. Despite high rates of sexually transmitted infections among PrEP users and reported decreases in condom use in a subset, there were no new HIV infections in this population.
Sin obras prominentes en esta página.
No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting
Referrals for and initiation of preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection increased dramatically in a large clinical practice setting since 2012. Despite high rates of sexually transmitted infections among PrEP users and reported decreases in condom use in a subset, there were no new HIV infections in this population.
Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System
BACKGROUND: Placebo-controlled and open-label studies have demonstrated the safety and efficacy of daily oral preexposure prophylaxis (PrEP) in preventing HIV infection, but data are limited on real-world PrEP use. METHODS: We conducted a cohort study from July 2012 through June 2015 of Kaiser Permanente Northern California members initiating PrEP. We assessed pharmacy refill adherence and discontinuation, decreases in estimated glomerular filtra…
HIV/AIDS Research and Interventions (2 obras) · Human immunodeficiency virus (HIV) (2 obras) · Immunology (2 obras) · Medicine (2 obras) · Men who have sex with men (2 obras) · Pre-exposure prophylaxis (2 obras) · Chlamydia (1 obras) · Clinical Practice (1 obras) · Condom (1 obras) · Confidence interval (1 obras)